Drugs / BGF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03836677 | Feb → Nov 2019 | chronic obstructive pulmonary disease | AstraZeneca | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03836677 ↗ |
| Route | Inhaled | “each delivered via a single metered dose Aerosphere inhaler” PMID 34210340 ↗ Jul 2021 |